SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaillie Gifford Shin Nippon PLC Share News (BGS)

Share Price Information for Baillie Gifford Shin Nippon PLC (BGS)

Share Price is delayed by 15 minutes
Get Live Data
157.40    0.20 (0.13%)
Bid:
156.60
Ask:
157.80
Spread: 1.20 (0.766%)
Market Cap: £313.93m
BGS Live PriceLast checked at - London Stock Exchange

Intraday Baillie Gifford Shin Nippon PLC Share Chart

Baillie Gifford Shin Nippon PLC News

UPDATE: Baillie Gifford Shin Nippon Chairman To Stand Down In May
14 Mar 2014

UPDATE: Baillie Gifford Shin Nippon Chairman To Stand Down In May

LONDON (Alliance News) - Baillie Gifford Shin Nippon PLC Friday said it has begun looking for a successor for Chairman Barry Rose, who will be resigni...

Baillie Gifford Shin Nippon Chairman To Stand Down In May
14 Mar 2014

Baillie Gifford Shin Nippon Chairman To Stand Down In May

LONDON (Alliance News) - Baillie Gifford Shin Nippon PLC Friday said it has begun looking for a successor for Chairman Barry Rose, who will be resigni...

Pension funds dig for yield in disaster insurance
8 Apr 2013

Pension funds dig for yield in disaster insurance

By Sarah Mortimer LONDON, April 8 (Reuters) - Pension funds are turning to specialist bonds that bet on the likelihood of a natural disaster, in a sea...

Good half for Baillie Gifford Shin
3 Sep 2010

Good half for Baillie Gifford Shin

A good half for shares of Japanese smaller companies helped Ballie Gifford's Shin Nippon investment trust outstrip both the broader Japanese market an...

Japan's laggards due a re-rating
7 Jul 2010

Japan's laggards due a re-rating

The Japanese economy has suffered with the best of them over the past few years, a situation made worse by a strong local currency and political uncer...

New Sinclair Pharma boss invests £822,000
13 Jan 2010

New Sinclair Pharma boss invests £822,000

Sinclair Pharma's new chief executive and two non-executive directors all increased their shareholdings after the specialist pharma company's recent f...